Market Report Israeli Stocks Set Two-and-a-half-year High

Teva buoyed by success of late-stage clinical trial to treat multiple sclerosis.

The Tel Aviv Stock Exchange closed at a two-and-a-half-year high Sunday, making up losses incurred Thursday when index compositions were rebalanced. Shares were pulled up by optimism and arbitrage gaps that opened over the weekend.